Bernstein Harold bought MAZE
January 5, 2026 · Form 4 insider transaction
Bernstein Harold bought 412 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $4.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
412
Price
$10.42
Total value
$4.3K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after412
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.